Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study.
Lucas MinigS CabreraR OliverA CousoM J RubioS IacoponiM B Martin-SalamancaS Carballo-RastrillaJ M Cádenas-RebolloA García-GarciaB Gil-IbáñezM J Juan-FitaM G PatronoPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2018)
The incidence of STIC after RRSO in BRCA mutation carriers is low (0.8%) and it presents an excellent oncological outcome. Patients after RRSO, however, run the risk to develop other types of cancer during follow-up and should be properly advised before the prophylactic surgery.
Keyphrases
- end stage renal disease
- breast cancer risk
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- risk factors
- coronary artery bypass
- prostate cancer
- rectal cancer
- cross sectional
- coronary artery disease
- radical prostatectomy
- squamous cell
- patient reported outcomes
- double blind
- lymph node metastasis